VRTX Earnings: A snapshot of Vertex Pharmaceuticals’ Q1 2023 results
Healthcare firm Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) on Monday reported a decline in adjusted earnings for the first quarter, despite an increase in revenues. Total revenues increased to $2.37 billion in […]
The post VRTX Earnings: A snapshot of Vertex Pharmaceuticals’ Q1 2023 results first appeared on AlphaStreet.